Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Grant or award Director acquired 7,500 shares (grant or award)
  2. 4 Grant or award Director acquired 7,500 shares (grant or award)
  3. 4 Grant or award Director acquired 7,500 shares (grant or award)
  4. 4 Grant or award Director acquired 7,500 shares (grant or award)
  5. 4 Grant or award Director acquired 7,500 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 100,000 shares (grant or award)
  7. 4 Grant or award EVP, CFO acquired 40,000 shares (grant or award)
  8. 4 Grant or award EVP, CSO and CMO acquired 40,000 shares (grant or award)
  9. 4 Open-market buy Director bought 20,000 shares at $3.50 ($70,000)
  10. 4 Open-market buy CSO and CMO bought 4,285 shares at $3.50 ($14,998)
  11. 4 Open-market buy Director bought 45,714 shares at $3.50 ($159,999)
  12. 4 Open-market buy EVP, CFO bought 7,142 shares at $3.50 ($24,997)
  13. 4 Open-market buy President and CEO bought 85,714 shares at $3.50 ($299,999)
  14. 4 Open-market buy 10% owner bought 4,563,700 shares at $3.50 ($15,972,950)
  15. 4 Open-market sale 10% owner sold 5,813,954 shares at $3.75 ($21,802,328)
  16. 4 Open-market buy 10% owner bought 4,000,000 shares at $4.00 ($16,000,000)
  17. 4 Open-market buy Director bought 12,000 shares at $4.00 ($48,000)
  18. 4 Open-market buy Director bought 25,000 shares at $4.00 ($100,000)
  19. 4 Open-market buy EVP, CSO and CMO bought 4,500 shares at $4.00 ($18,000)
  20. 4 Open-market buy EVP, CFO bought 5,000 shares at $4.00 ($20,000)

Page 10 of 19 · 364 filings